# US 2003/0078282 A1 · Novel 4-phenylpiperidines for the treatment of pruritic dermatoses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0078282 A1
- Document ID: US20030078282A1
- Status: Published application
- Kind: A1
- Application number: 09/646,255
- Filed: 2000-05-11
- Published: 2003-04-24
- Earliest claimed: 1998-05-18
- Assignees: Pfizer Inc.
- Inventors: Richard Edward Armer; Christopher James Dutton; David Morris Gethin; Stephen Paul Gibson; Julian Duncan Smith; Ivan Tommasini
- Web page: https://patentgrep.com/patent/US20030078282A1

## CPC

- C07D 211/26: with hydrocarbon radicals, substituted by nitrogen atoms
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/04: Antipruritics
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- C07D 211/28: to which a second hetero atom is attached
- C07D 211/94: Oxygen atom, e.g. piperidine N-oxide
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Novel compounds having general formula (I), and pharmaceutically and veterinarily acceptable salts thereof wherein R 1, R 2, R 3, W, Y 1, Y 2, X, n and y are as defined above and processes for their preparation and intermediate compounds prepared therein. The novel compounds are useful for having utility in the treatment. of pruritic dermatoses including allergic dermatitis and atopy in animals and humans

## Claims

### Claim 1

A compound having the general formula:
73
and pharmaceutically and veterinarily acceptable salts thereof wherein:
R1 and R2 are each independently H or C1-C4 alkyl; R3 is C1-C10 alkyl, C3-C10 alkenyl, or C3-C10 alkynyl; wherein said alkyl, alkenyl or alkynyl group may optionally be substituted by one or more substituents independently chosen from:
OH; CN; one or more halo atoms; C1-C6 alkoxy; C1-C6 alkoxycarbonyl; C2-C6 alkanoyl; C2-C6 alkanoyloxy; C3-C8 cycloalkyl; C3-C8 cycloalkoxy; C4-C9 cycloalkanoyl; aryl; aryloxy; aryl(C1-C4)alkoxy; heteroaryl; a saturated heterocyclic group; adamantyl or ZBNR4R5 wherein Z is a direct bond, CO or S(O)p wherein p=0, 1, 2 and wherein B=(CH2)m wherein m=from 0 to 10 and wherein R4 and R5 are independently selected from H, C1-C10 alkyl, C3-C10 alkenyl, C3-C10 alkynyl, C3-C8 cycloalkyl, aryl or heteroaryl or wherein R4 and R5 represent unbranched C2-C6 alkylene groups which when taken together with the N to which they are bonded form a 4 to 7 membered saturated heterocyclic ring optionally containing O, S or N—R6 wherein said heterocyclic ring may be substituted by one or more C1-C4 alkyl groups and wherein R6 is H, C1-C6 alkyl, C3-C8 cycloalkyl, —(C1-C6 alkylene)(C3-C8 cycloalkyl) or —(C1-C6 alkylene)aryl and wherein when Z is a direct bond and m=0, then R3 is not a terminal alkenyl or alkynyl;
W is SO2, C═O, P(Y1)═O or P(Y1)═S;
X is one or more substitutents independently selected from H, halo, C1-C4 alkyl, C1-C4 alkoxy, halo (C1-C4) alkyl or halo(C1-C4)alkoxy;
Y1 is C1-C10 alkyl which may optionally be substituted by one or more halo atoms or by OH, C1-C4 alkoxy, C2-C6 alkanoyloxy, CONH2, NH2 or aryl; NH2, mono- or di-(C1-C4) alkylamino, C3-C8 cycloalkyl, aryl, phthalimidyl or heteroaryl;
Y2 is H, C1-C4 alkyl, or C3-C6 alkenyl, wherein said alkyl or alkenyl groups may optionally be substituted by aryl, aryloxy or heteroaryl;
n is 0, 1 or 2; and
y is 0 or 1.

### Claim 2 (depends on 1)

Compounds according to claim 1 wherein N(Y2)(WY1) is in the meta position, y=0, W=SO2, R1 and R2 are C1-C4 alkyl groups with trans relative stereochemistry, or R1 is a C1-C4 alkyl group and R2 is hydrogen; Y2 is hydrogen and wherein:
Y1 is C1-C10 alkyl; imidazolyl or pyridyl; mono- or di-C1-C3 alkyl; phenyl; or C1-C10 alkyl substituted by C1-C2 alkoxy, or phenyl and wherein,
R3 is selected from: C4-C10 straight or branched chain alkyl; or;
C1-C10 alkyl substituted by: C5-C6 cycloalkyl, optionally substituted by one or more C1-C4 alkyl groups; C3-C4 alkoxy; C5-C6 cycloalkyloxy; aryloxy, optionally mono-substituted at the ortho position by chloro, or, at the ortho or para positions for fluoro, bromo, iodo, or at the ortho position for C1-C2 alkyl; aryl(C1-C2)alkoxy; C5-C6 cycloalkanoyl; saturated 5- or 6-membered heterocyclic ring wherein the heteroatom(s) are at the 2- or 4-positions; or heteroaryl selected from isoxazolyl or indolyl; or;
C1-C10 alkyl substituted by: aryl, optionally substituted by one or more C1-C4 alkyl or halo groups or CH2CN; ZNR4R5 wherein Z is carbonyl or a direct link, R4 is hydrogen and R5 is C5-C6 cycloalkyl; or
C2-C10 alkyl substituted by hydroxy and C5-C6 cycloalkyl; or
C3-C10 alkenyl; or C3-C4 alkenyl substituted by: C5-C6 cycloalkyl; aryl; or
C3-C10 alkynyl.

### Claim 3 (depends on 1, 2)

Compounds according to claims 1 and 2 wherein R1 and R2 are methyl groups with trans relative stereochemistry.

### Claim 4 (depends on 1, 2)

Compounds according to claims 1 and 2 wherein R1 is propyl and R2is hydrogen.

### Claim 5 (depends on 1, 2, 3)

Compounds according to any one of claims 1 to 3 wherein N(Y2)(WY1) is in the meta position, y is zero, n is zero, W=SO2, R1 and R2 are methyl groups with trans relative stereochemistry; Y2 is hydrogen and wherein Y1 is methyl, ethyl, propyl, 1-methylethyl or butyl; imidazolyl or pyridinyl or N-isopropylamino and wherein R3 is selected from: hexyl; methyl-hexyl; or ethyl or propyl substituted by: cyclohexyl; cyclohexanoyl; 2-tetrahydropyranyl or methyl, ethyl or propyl, substituted by: phenyl; or 3-cyclohexyl-3-hydroxypropyl; or prop-2-enyl substituted by cyclohexyl or phenyl.

### Claim 6 (depends on 5)

Compounds according to claim 5 wherein Y1 is selected from: methyl, ethyl, propyl, 1-methylethyl, butyl, 3-pyridinyl, 1-methyl-1H-imidazol-4-yl and N-isopropylamino.

### Claim 7 (depends on 5)

Compounds according to claim 5 wherein R3 is selected from: N-hexyl, N-(5-methylhexyl), N-(3-cyclohexylpropyl), N-benzyl, N-(3-phenylpropyl), N-(3-cyclohexyl-3-oxopropyl), N-(2-(3-methylphenyl)ethyl), N-(1-(4-ethylphenyl)methyl), N-(2-(2-methylphenyl)ethyl), N-(3-(2-methylphenyl)propyl), N-(3-(tetrahydropyran-2-yl)propyl), N-((S)-3-cyclohexyl-3-hydroxy propyl), N-((E)-3-cyclohexylprop-2-enyl) and N-cinnamyl.

### Claim 8 (depends on 5)

Compounds according to claim 5 wherein Y1 is selected from methyl, ethyl, propyl and wherein R3 is: hexyl or 5-methylhexyl; or methyl or ethyl substituted by phenyl, substituted methyl or ethyl; or propyl substituted by phenyl.

### Claim 9

Compounds according to any of the preceding claims wherein Y1 is selected from methyl, ethyl or propyl.

### Claim 10

Compounds according to any of the preceding claims wherein R3 is selected from: N-hexyl, N-(5-methylhexyl), N-benzyl, N-(3-phenylpropyl), N-(2-(3-methylphenyl)ethyl), N-(2-(2methylphenyl)ethyl) and N-(3-(2-methylphenyl) propyl).

### Claim 11

Compounds according to any of the preceding claims selected from:
(±)-4-(3-ethanesulfonylaminophenyl)-N-hexyl-trans-3,4-dimethylpiperidine,
(+)-4-(3-ethanesulfonylaminophenyl)-N-hexyl-trans-3,4-dimethylpiperidine,
(±)-4-(3-ethanesulfonylaminophenyl)-trans-3,4-dimethyl-N-(5-methylhexyl)piperidine,
(±)-trans-3,4-dimethyl-N-(5-methylhexyl)-4-(3-propanesulfonylaminophenyl)piperidine,
(±)-N-hexyl-trans-3,4-dimethyl-4-(3-propanesulfonylaminophenyl)piperidine,
(±)-N-benzyl-trans-3,4-dimethyl-4-(3-propanesulfonylaminophenyl)piperidine,
(±)-trans-3,4-dimethyl-N-(3-phenylpropyl)-4-(3-propanesulfonylaminophenyl)piperidine,
(±)-4-(3-methanesulfonylaminophenyl)-trans-3,4-dimethyl-N-(5-methylhexyl)piperidine,
(±)-N-hexyl-4-(3-methanesulfonylaminophenyl)-trans-3,4-dimethylpiperidine,
(±)-4-(3-methanesulfonylaminophenyl)-trans-3 ,4-dimethyl-N-(2-(3-methylphenyl)-ethyl)piperidine,
(±)-4-(3-methanesulfonylaminophenyl)-trans-3,4-dimethyl-N-(3-phenylpropyl)piperidine,
(±)-4-(3-methanesulfonylaminophenyl)-trans-3,4-dimethyl-N-(2-(2-methylphenyl)ethyl)piperidine and
(±)-4-(3-methanesulfonylaminophenyl)-trans-3,4-dimethyl-N-(3-(2-methylphenyl)propyl)piperidine and pharmaceutical salts thereof.

### Claim 12

A process for the formation of compounds and salts having the general formula (I):
74
wherein: R1 and R2 are each independently H or C1-C4alkyl; R3 is C1-C10 alkyl, C3-C10 alkenyl, or C3-C10 alkynyl; wherein said alkyl, alkenyl or alkynyl group may optionally be substituted by one or more substituents independently chosen from:
OH; CN; one or more halo atoms; C1-C6 alkoxy; C1-C6 alkoxycarbonyl; C2-C6 alkanoyl; C2-C6 alkanoyloxy; C3-C8 cycloalkyl; C3-C8 cycloalkoxy; C4-C9 cycloalkanoyl; aryl; aryloxy; aryl(C1-C4)alkoxy; heteroaryl; a saturated heterocyclic group; adamantyl or ZBNR4R5 wherein Z is a direct bond, CO or S(O)p wherein p=0, 1, 2 and wherein B=(CH2)m, wherein m=from 0 to 10 and wherein R4 and R5 are independently selected from H, C1C10 alky, C3-C10 alkenyl, C3-C10 alkenyl, C3-C8 cycloalkyl, aryl or heteroaryl or wherein R4 and R5 represent unbranched C2-C6 alkylene groups which when taken together with the N to which they are bonded form a 4 to 7 membered saturated heterocyclic ring optionally containing O, S or N—R6 wherein said heterocyclic ring may be substituted by one or more C1-C4 alkyl groups and wherein R6 is H, C1-C6 alkyl, C3-C8 cycloalkyl, —(C1-C6 alkylene)(C3-C8 cycloalkyl) or —(C1-C6 alkylene)aryl and wherein when Z is a direct bond and m=0, then R3 is not a terminal alkenyl or alkynyl;
W is SO2, C═O, P(Y1)═O or P(Y1)═S;
X is one or more substitutents independently selected from H, halo, C1-C4 alkyl, C1-C4 alkoxy, halo (C1-C4) alkyl or halo(C1-C4)alkoxy;
Y1 is C1-C10 alkyl which may optionally be substituted by one or more halo atoms or by OH, C1-C4 alkoxy, C2-C6 alkanoyloxy, CONH2, NH2 or aryl; NH2, mono or di-(C1-C4) alkylamino, C3-C8 cycloalkyl, aryl, phthalimidyl or heteroaryl;
Y2 is H, C1-C4 alkyl, or C3-C6 alkenyl, wherein said alkyl or alkenyl groups may optionally be substituted by aryl, aryloxy or heteroaryl;
n is 0, 1 or 2; and
y is 0 or 1.
said process comprising reacting a compound having the general formula (IIa):
75
wherein R1, R2, R3, X, Y2 and n are as defined above, by reaction with either a group of the formula Q—W—Y1, in the presence of a base, wherein W and Y1 are as defined above and Q is a leaving group; or with an anhydride of the formula (Y1W)2O in the presence of a base.

### Claim 13

A process for the preparation of compounds and salts having the general formula (I):
76
wherein: R1 and R2 are each independently H or C1-C4 alkyl; R3 is C1-C10 alkyl, C3-C10 alkenyl, or C3-C10 alkynyl; wherein said alkyl, alkenyl or alkynyl group may optionally be substituted by one or more substituents independently chosen from:
OH; CN; one or more halo atoms; C1-C6 alkoxy; C1-C6 alkoxycarbonyl; C2-C6 alkanoyl; C2-C6 alkanoyloxy; C3-C8 cycloalkyl; C3-C8 cycloalkoxy; C4-C9 cycloalkanoyl; aryl; aryloxy; aryl(C1-C4)alkoxy; heteroaryl; a saturated heterocyclic group; adamantyl or ZBNR4R5 wherein Z is a direct bond, CO or S(O)p wherein p=0, 1, 2 and wherein B=(CH2)m wherein m=from 0 to 10 and wherein R4 and R5 are independently selected from H, C1-C10 alkyl, C3-C10 alkenyl, C3-C10 alkynyl, C3-C8 cycloalkyl, aryl or heteroaryl or wherein R4 and R5 represent unbranched C2-C6 alkylene groups which when taken together with the N to which they are bonded form a 4 to 7 membered saturated heterocyclic ring optionally containing O, S or N—R6 wherein said heterocyclic ring may be substituted by one or more C1-C4 alkyl groups and wherein R6 is H, C1-C6 alkyl, C3-C8 cycloalkyl, —(C1-C6 alkylene)(C3-C8 cycloalkyl) or —(C1-C6 alkylene)aryl and wherein when Z is a direct bond and m=0, then R3 is not a terminal alkenyl or alkynyl;
W is SO2, C═O, P(Y1)═O or P(Y1)═S;
is one or more substitutents independently selected from H, halo, C1-C4 alkyl, C1-C4 alkoxy, halo (C1-C4) alkyl or halo(C1-C4)alkoxy;
Y1 is C1-C10 alkyl which may optionally be substituted by one or more halo atoms or by OH, C1-C4 alkoxy, C2-C6 alkanoyloxy, CONH2, NH2 or aryl; NH2, mono or di-(C1-C4)-alkylamino, C3-C8 cycloalkyl, aryl, phthalimidyl or heteroaryl;
Y2is H, C1-C4 alkyl, or C3-C6 alkenyl, wherein said alkyl or alkenyl groups may optionally be substituted by aryl, aryloxy or heteroaryl;
n is 0, 1 or2; and
y is 0 or 1;
said process comprising reaction of a compound of general formula (IIIa):
77
wherein R1, R2, Y1, Y2, W, X and n are as defined above, with a compound of formula R3—X, wherein R 3 is as defined above and wherein X is chloro, bromo, iodo or a suitable leaving group.

### Claim 14 (depends on 12, 13)

A process according to claim 12 or 13 for the preparation of compound of the general formula (Ib):
78
wherein N(Y2)(WY1) is in the meta position and y is zero.

### Claim 15 (depends on 14)

A process according to claim 14 wherein the compound having general formula (I) is a compound having the general formula (XXIV):
79
wherein Y1 is methyl, ethyl or propyl and R3 is selected from: N-hexyl, N-(5-methylhexyl), N-benzyl, N-(3-phenylpropyl), N-(2-(3-methylphenyl)ethyl), N-(2-(2-methylphenyl)ethyl) or N-(3-(2-methylphenyl)propyl) and wherein the compound having general formula (II) is a compound having the general formula (XXIII):
80
wherein the reagents are (Y1SO2)2O or Y1SO2Cl.

### Claim 16 (depends on 15)

A process according to claim 15 wherein the molar ratio of (Y1SO2)2O or Y1SO2Cl to compound (XXIII) is at least 2:1 and wherein the reaction of compound (XIII) with (Y1SO2)2O or Y1SO2Cl is followed by alkaline hydrolysis.

### Claim 17 (depends on 12, 13, 14, 15, 16)

A process according to any of claims 12 to 16 wherein compounds having the general formula (I) are subsequently converted to a salt and recrystallised.

### Claim 18 (depends on 15, 17)

A process according to claim 17 wherein the compound having the general formula (I) is a compound having the general formula (XXIV) as defined in claim 15 and wherein the salt formed is the (+)- or (−)-camphorsulfonic acid salt.

### Claim 19 (depends on 12, 14)

A process for the formation of compounds having the general formula (II) comprising hydrolysing compounds having the general formula (XIV):
81
wherein R1, R2, R3, X and n are as defined for the compound of formula (I) in claim 12 with the proviso that the R3 group is not substituted by CN or C1-C6 alkoxycarbonyl and wherein y and N(Y2)(WY1) are as defined in claim 14.

### Claim 20 (depends on 12, 19)

A process for the formation of compounds having the general formula (XIV) as defined in claim 19 comprising reaction of a compound of general formula (XIII):
82
wherein L is a bromo, iodo, or OSO2CF3 group and wherein R1, R2, R3, X and n are as defined for a compound of formula (I) in claim 12 with the proviso that the R3 group is not substituted by CN or C1-C6 alkoxycarbonyl and wherein y is zero with the proviso that (X)n is not a bromo or iodo group,
said reaction comprising reacting a compound of general formula (XIII) with benzophenone imine in the presence of a palladium catalyst and a base.

### Claim 21 (depends on 19, 20)

A process according to claims 19 and 20 wherein the compounds having the general formula (II) are formed from compounds having the general formula (XIII) by:
a) reaction with benzophenone imine in the presence of a palladium catalyst, a ligand, and base to form a compound of general formula (XIV); followed by
b) acid hydrolysis; and
wherein the intermediate compound having the general formula (XIV) is not isolated.

### Claim 22 (depends on 21)

A process according to claim 21 wherein the base is sodium tertiary butoxide or caesium carbonate.

### Claim 23 (depends on 12, 15, 19, 20, 21, 22)

A process according to any of claims 19 to 22 wherein the compound having the general formula (XIII) is a compound having the general formula (XXII):
83
wherein L is a bromo or iodo group and R3 is as defined in claim 12 and wherein the reaction is carried out with palladium diacetate, (R)-(+)-2,2′-bis (diphenylphosphino)-1,1′-binaphthyl, benzophenone imine and sodium tertiary butoxide in toluene followed by acid hydrolysis to form a compound having the general formula (XXIII) as defined in claim 15.

### Claim 24 (depends on 12, 19)

A process according to claim 19 for the formation of compounds having the general formula (II) as defined in claim 12 wherein y is zero and wherein the NHY2 group is in the meta position from compounds having the general formula (XXV) via compounds having the general formula (XIV) as defined in claim 19:
84
wherein R1, R2, R3, X and n are as defined for the compounds of general formula (I) in claim 12, with the proviso that the R3 group is not substituted by CN or C1-C6 alkoxycarbonyl, which are in turn prepared from the corresponding alcohols having the general formula (V).
85
wherein R1, R2, R3, X and n are as defined in claim 12.

### Claim 25 (depends on 12)

A process for the formation of compounds having the general formula (II) as defined in claim 12 wherein y is zero via reduction of compounds having the general formula (XIII) wherein L is —NO2.

### Claim 26 (depends on 12, 15)

A process for the formation of compounds having the general formula (XIII), as defined in claim 15 from compounds having the general formula (XII):
86
wherein L is a bromo, iodo, —NO2 or —OR15 group, and wherein R1, R2, R3, X and n are as defined for a compound of general formula (I) in claim 12 with the provisos that: the R3 group is not substituted by C1-C6 alkoxycarbonyl, C2-C6 alkanoyl or C2-C6 alkanoyloxy, or by ZBNR4R5 wherein Z is CO; when L is bromo or iodo (X)n is not a bromo, iodo; when L is —OR15, (X)n is not a bromo, iodo or alkoxy group, and wherein L′ and L″ are leaving groups derived from alcohol which are displaceable by an amine selected from alkyl or arylsulfonate or halo and wherein R15 is a C1-C4 alkyl group;
said reaction comprising reaction of a compound having general formula (XII) with an amine of the formula NH2R3 or NH3 wherein R3 is as defined in claim 12.

### Claim 27 (depends on 26)

A process according to claim 26 wherein L′ and L″ are each independently selected from alkyl sulfonyloxy, aryl sulfonyloxy or halogen.

### Claim 28 (depends on 23, 26, 27)

A process according to claims 26 and 27 wherein the compound having the formula (XII) is a compound having the general formula (XXI):
87
wherein L is a bromo or iodo group and wherein L′ and L″ are as defined in claim 26 and wherein the reaction is carried out with n-hexylamine, aqueous sodium carbonate and toluene to provide compounds having the general formula (XXII) as defined in claim 23.

### Claim 29 (depends on 25, 26, 27)

A process for the formation of a compound having general formula (XII) as defined in any of claims 25 to 27 comprising reacting a compound having the general formula (XI):
88
wherein R1, R2, L, X and n are as defined in claim 26; with
a) an alkyl or arylsulfonylhalide or anhydride in the presence a base in an inert solvent; and, optionally,
b) conversion of the diol (XI) to its corresponding dihalo derivative.

### Claim 30 (depends on 26, 29)

A process for the formation of a diol having general formula (XI) as defined in claim 29 from a γ,δ unsaturated acid having the general formula (X):
89
wherein R1, R2, L, X and n are as defined in claim 26;
said process comprising reduction of the acid group and concomitant hydroboration of the alkene group followed by subsequent oxidative work-up provides the diol (XI).

### Claim 31 (depends on 30)

A process according to claim 30 wherein the acid having the general formula (X) is a compound having the general formula (XIX):
90
wherein L is a bromo or iodo group and wherein hydroboration of (XIX) with diborane in tetrahydrofuran followed by treatment with aqueous sodium percarbonate provides compounds having the general formula (XX):
91
wherein L is as defined above.

### Claim 32 (depends on 26, 30, 31)

A process for the formation of compounds having the general formula (X), as defined in claims 30 and 31, by alkaline hydrolysis of compounds having the general formula (IX):
92
wherein L is a bromo or iodo group and wherein R1, R2 L, X and n are as defined in claim 26 and wherein R13 is a C1-C4 alkyl group.

### Claim 33 (depends on 26, 32)

A process for the formation of a compound having the general formula (IX) as defined in claim 32 from a compound having general formula (VIII):
93
wherein R1, R2, L, X and n are as defined in claim 26;
said process comprising reacting (VII) with a compound of the formula MeC(OR13)3 wherein R13 is C1-C4 alkyl or aryl, with subsequent thermal rearrangement to furnish compounds having the general formula (IX).

### Claim 34 (depends on 33)

A process according to claim 33 wherein the compound having the general formula (VII) is a compound having the general formula (XVI):
94
wherein L is a bromo or iodo group and wherein said compound (XVI) is reacted with CH3C(OCH3)3 to provide an intermediate compound having the general formula (XVII):
95
wherein L is a bromo or iodo group and wherein compound (XVII) rearranges upon heat treatment to provide a compound having the general formula (XVIII).
96

### Claim 35 (depends on 26, 33, 34)

A process for the formation of compounds having the general formula (VIII), as defined in claims 33 and 34, from compounds having the general formula (VII):
97
wherein R1, R2, L, X and n are as defined in claim 26 and wherein R12 is a C1-C4 alkyl group;
comprising reduction of the α,β unsaturated ester group via reaction with a metal hydride in an inert solvent.

### Claim 36 (depends on 35)

A process according to claim 35 wherein the compound having the general formula (VII) is a compound having the general formula (XV):
98
wherein L is a bromo or iodo group.

### Claim 37 (depends on 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

A process according to any of claims 12 to 36 wherein an optional separation of -cis and -trans geometric isomers of compounds having the general formulae (VII), (VIII), (XV) or (XVI) is carried out using chromatographic techniques and wherein an optional optical resolution of the —(R) and —(S) isomers of compounds having the general formulae (X) or (XIX) is carried out via treatment with a chiral amine followed by recrystallisation; and wherein an optional separation of -cis and -trans diastereoisomers of diols having the general formulae (XI) or (XX) is carried out via recrystallisation or chromatographic techniques; and wherein an optional resolution of the racemic mixture of compounds having the general formulae (I), with the proviso that y is zero, or (XXIV) is carried out via recrystallisation or chromatographic techniques.

### Claim 38 (depends on 12, 14, 15)

A process according to claims 12, 14 and 15 wherein compounds of the general formulae (I) or (XXIV) are treated with (+) or (−) camphorsulfonic acid (CSA) followed by resolution of the resultant diastereomeric (+) and (−) CSA salts.

### Claim 39 (depends on 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

A process according to any of claims 12 to 36 wherein no resolution is performed throughout and wherein separation of the enantiomers diastereoisomers of formula (I) is accomplished via chiral phase HPLC.

### Claim 40 (depends on 12)

A compound having the general formula (IIa):
99
wherein R1, R2, R3, X, Y2 and n are as defined in claim 12 and wherein y is zero.

### Claim 41 (depends on 13)

A compound having the general formula (IIIa):
100
wherein R1, R2, Y1, Y2, X and n are as defined in claim 13.

### Claim 42 (depends on 12)

A compound having the general formula (VI):
101
wherein R1, R2, R3, X and n are as defined in claim 12.

### Claim 43 (depends on 19)

A compound having the general formula (XIV):
102
wherein R1, R2, R3, X and n are as defined in claim 19.

### Claim 44 (depends on 12)

A compound having the general formula (XIII):
103
wherein L is a bromo, iodo, or OSO2CF3 group and wherein R1, R2, R3, X and n are as defined for a compound of formula (I) in claim 12 with the proviso that the R3 group is not substituted by CN or (C1-C6)alkoxycarbonyl and wherein y is zero with the proviso that (X)n is not a bromo or iodo group.

### Claim 45 (depends on 12)

A compound having the general formula (XII):
104
wherein L is a bromo, iodo, —NO2 or —OR15 group, and wherein R1, R2, R3 X and n are as defined for a compound of general formula (I) in claim 12 with the provisos that: the R3 group is not substituted by C1-C6 alkoxycarbonyl, C2-C6 alkanoyl or C2-C6 alkanoyloxy, or by ZBNR4R5 wherein Z is CO; when L is bromo or iodo (X)n is not a bromo, iodo; when L is —OR15, (X)n is not a bromo, iodo or alkoxy group, and wherein L′ and L″ are leaving groups derived from alcohol which are displaceable by an amine selected from alkyl or arylsulfonate or halo and wherein R15 is a C1-C4 alkyl group.

### Claim 46 (depends on 45)

A compound having the general formula (X):
105
wherein R1, R2, L, X and n are as defined in claim 45;

### Claim 47

A pharmaceutical composition comprising a compound of formula (I), or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable diluent or carrier.

### Claim 48

A veterinary formulation comprising a compound of formula (I), or a veterinarily acceptable salt thereof, together with a veterinarily acceptable diluent or carrier.

### Claim 49

A compound of formula (I), or a pharmaceutically or veterinarily acceptable salt thereof, for use as a human or animal medicament.

### Claim 50

The use of a compound of formula (I), or a pharmaceutically or veterinarily acceptable salt thereof, for the manufacture of a medicament for the curative or prophylactic treatment of pruritus in a human or animal.

### Claim 51

A method of treating or preventing pruritus in a human or animal which comprises administering a therapeutically effective amount of a compound of formula (I), or a pharmaceutically or veterinarily acceptable salt thereof.
